$0.3466
-0.0759-17.96%
Last update: Sep 11, 3:19 PM

Silexion Therapeutics (SLXN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.12 | $-12.90 | $-11.40 | — |
| Actual | $-5.17 | $-8.50 | $-14.00 | $-28.80 |
| Surprise | -143.9% | +34.1% | -22.8% | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.91 | $-0.71 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-5.17 | $-2.12 | -143.9 % |
| Q1 | May 15, 2026 | $-8.50 | $-12.90 | 34.1 % |
| Q4 | Mar 17, 2026 | $-14.00 | $-11.40 | -22.8 % |